Company intelligence / Profile preview

IV Solution and Ketamine Centers of Chicago

Chicago, Illinois, United States

Ownership: Private
Development stage: Other

Overview

The company has performed over 15,000 ketamine infusions since 2017 with strong clinical outcomes reported for treatment-resistant psychiatric and pain disorders; clinical results are backed by internal data and peer-reviewed collaborations but no NDA-regulated drugs.

Therapeutic areas: Women's HealthNeurologyRheumatologyPsychiatry
Modalities: Small molecule
Industry: Non-Academic Healthcare

Partnerships

Baylor College of Medicine Department of PsychiatryDepartment of Veterans Affairs (VA)

Beyond the preview

Go deeper on IV Solution and Ketamine Centers of Chicago.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on IV Solution and Ketamine Centers of Chicago.

Explore the full profile